orthospinenews.com /3 days ago

Fziomed Announces FDA 510(k) Clearance for DynaviscВ® Tendon Protector in the United States

SAN LUIS OBISPO, Calif., Nov. 18, 2026 /PRNewswire/ — Fziomed, Inc. (“Fziomed” or the “Company”), a global leader in postsurgical adhesion prevention…

Read source
orthotw.com /4 days ago

Fziomed Announces FDA 510(k) Clearance for Dynavisc® Tendon Protector in the United States

FDA clearance expands Fziomed's U.S. portfolio of innovative, fully synthetic biomaterials for surgical applications.

Read source
orthotw.com /3 weeks ago

Vivex Biologics' VIA Disc® NP Meets Primary Endpoint in Pivotal, Sham-Controlled ASCEND Trial Published in Journal of Cl...

The first intradiscal allograft to succeed in a rigorous, sham-controlled trial for chronic lumbar discogenic pain, a leading driver of the world’s #1 cause of disability.

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.